Serial electrophysiologic studies after single chamber atrial pacemaker implantation in patients with symptomatic...

Area of Science:

• Cardiology
• Electrophysiology
• Pharmacology

Background:

• Symptomatic sinus node dysfunction often requires atrial pacemaker implantation.
• Maintaining intact anterograde atrioventricular (AV) conduction is crucial for optimal pacing outcomes.
• The long-term effects of antiarrhythmic drugs on AV conduction in these patients are not fully understood.

Purpose of the Study:

• To investigate the impact of antiarrhythmic drug therapy on anterograde AV conduction in patients with sinus node dysfunction post-atrial pacemaker implantation.
• To differentiate between drug-induced effects and natural system degeneration on AV conduction.

Main Methods:

• Serial noninvasive electrophysiologic studies were conducted every 3 months for 3 years in 24 patients.
• Patients were divided into two groups: those not requiring antiarrhythmic drugs and those on medication.
• Atrial paced heart rate producing AV Wenckebach phenomenon (AVWHR) was measured and compared pre- and post-pacemaker implantation and during follow-up.

Main Results:

• In patients not on antiarrhythmic drugs (Group I, n=11), AVWHR remained stable throughout follow-up (mean 22 months).
• In patients receiving antiarrhythmic drugs (Group II, n=13), a significant decrease in AVWHR was observed within 3 months of drug initiation (P < 0.01).
• Chronic antiarrhythmic drug therapy maintained this reduced AVWHR with minimal variability.

Conclusions:

• Deterioration of anterograde AV conduction in patients with sinus node dysfunction and initially intact AV conduction is primarily attributable to oral antiarrhythmic drugs.
• Antiarrhythmic drug therapy, rather than natural degeneration, is the likely cause of AV conduction impairment during long-term follow-up.
• These findings highlight the importance of considering medication effects when assessing AV conduction changes in pacemaker patients.